CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Press releases

04/01/2021

Changes of Management Board per April

more chevron_right
Press releases

03/01/2021

Changes of CHEPLAPHARM Management Board per March

more chevron_right
Investor Relations

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investors Domain

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investor Relations

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Press releases

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Investors Domain

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right
Press releases

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right
Back to top expand_less